Literature DB >> 3316501

The significance of clinically defined subgroups of Alzheimer's disease.

H C Chui1.   

Abstract

The significance of clinically defined subgroups of Alzheimer's disease (AD) is discussed within a framework of etiologic, pathogenetic, and treatment issues. Cerebral amyloid angiopathy and familial AD are proposed as etiologic subtypes. Clinical heterogeneity associated with age at onset and sex are thought to reflect the presence of secondary pathogenetic factors. Longitudinal studies are necessary to clarify the meaning of various symptomatic patterns.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316501

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  6 in total

1.  Alzheimer's disease: rapid and slow progression.

Authors:  Craig J Thalhauser; Natalia L Komarova
Journal:  J R Soc Interface       Date:  2011-06-08       Impact factor: 4.118

2.  Dermatoglyphic patterns in dementia of the Alzheimer type: a case-control study.

Authors:  C Berr; N Okra-Podrabinek; D Feteanu; S Taurand; M P Hervy; F Forette; F Piette; R Sebag-Lanoe; A Alperovitch
Journal:  J Epidemiol Community Health       Date:  1992-10       Impact factor: 3.710

3.  First-in-Rat Study of Human Alzheimer's Disease Tau Propagation.

Authors:  Tomas Smolek; Santosh Jadhav; Veronika Brezovakova; Veronika Cubinkova; Bernadeta Valachova; Petr Novak; Norbert Zilka
Journal:  Mol Neurobiol       Date:  2018-05-16       Impact factor: 5.590

4.  Calculating stage duration statistics in multistage diseases.

Authors:  Natalia L Komarova; Craig J Thalhauser
Journal:  PLoS One       Date:  2011-12-07       Impact factor: 3.240

5.  High degree of heterogeneity in Alzheimer's disease progression patterns.

Authors:  Natalia L Komarova; Craig J Thalhauser
Journal:  PLoS Comput Biol       Date:  2011-11-03       Impact factor: 4.475

6.  Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates.

Authors:  Helen Ling; Ellen Gelpi; Karen Davey; Zane Jaunmuktane; Kin Y Mok; Edwin Jabbari; Roberto Simone; Lea R'Bibo; Sebastian Brandner; Matthew J Ellis; Johannes Attems; David Mann; Glenda M Halliday; S Al-Sarraj; J Hedreen; James W Ironside; Gabor G Kovacs; E Kovari; S Love; Jean Paul G Vonsattel; Kieren S J Allinson; Daniela Hansen; Teisha Bradshaw; Núria Setó-Salvia; Selina Wray; Rohan de Silva; Huw R Morris; Thomas T Warner; John Hardy; Janice L Holton; Tamas Revesz
Journal:  Acta Neuropathol       Date:  2020-01-16       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.